On 9 November 2026, the US Commerce Department’s Bureau of Industry and Security (BIS) published a final rule in the Federal Register extending the suspension of its “Affiliates Rule” through 10 January 2027. The rule had been due to return on 10 November 2026, the day after the original one-year pause ended. The extension took effect on publication, so there was no gap in the suspension.
What happened
The Affiliates Rule was issued on 29 September 2025. It extended Entity List and Military End User (MEU) List restrictions to non-US entities that are 50 percent or more owned, individually or in aggregate, by listed parties. In November 2025 BIS suspended it for one year as part of a US-China trade arrangement, with the suspension due to run to 9 November 2026.
The new rule, “Extension of the Suspension of Expansion of End-User Controls for Affiliates of Certain Listed Entities” (Federal Register document 2026-22793, 9 November 2026), moves the end of that pause to 10 January 2027. Law-firm analysis describes the change as one of timing only: it does not alter the substance of the Affiliates Rule, and BIS has said it will address public comments on the rule in later rulemaking. Absent further BIS action, the license requirements would take effect on 10 January 2027. Commentary links the extension to the US-China trade understanding reached in Busan, which was also extended to the same date.
What it is not
- It is not a repeal. The rule’s regulatory text and its reimposition mechanism remain in place, and BIS retains authority to bring the restrictions back.
- It is not a long-term settlement. The pause now covers roughly two further months.
- It does not change the underlying Entity List itself. Parties already named on the Entity List or MEU List remain subject to their existing restrictions.
Why it matters to universities and research offices
For institutions with foreign collaborators, vendors, equipment suppliers and sponsors, the practical effect of the rule would be that a counterparty not itself listed could become restricted because of who owns it. Ordinary name-based restricted-party screening would not catch that. Compliance practitioners advising on the extension suggest the following preparation, which is general information rather than legal advice:
- Rescreen ownership, not only names. Check partner institutions, spin-outs, suppliers and sponsors for ownership of 50 percent or more by listed parties, including combined minority holdings.
- Close visibility gaps. Where public or vendor data is thin, ask counterparties directly for ownership information.
- Review agreements. Confirm that sponsored-research, subaward, procurement and material-transfer terms can accommodate a restriction that reappears at short notice.
- Update red flags. Treat significant minority ownership or other ties to listed parties as triggers for escalation to the export control or research security office.
- Watch the calendar. Monitor Federal Register notices ahead of 10 January 2027 and plan as though the pause is temporary.
Work involving export-controlled research already requires institutional screening and licensing review; the Affiliates Rule would widen the set of foreign parties that screening has to reach. For wider context on BIS enforcement, see our analysis of export control enforcement trends in 2026.
What to watch next
The next decision point is 10 January 2027. BIS could extend the suspension again, modify the rule, or let it take effect. Institutions should check the Federal Register and BIS announcements, and consult their export control officer or counsel about their own exposure.
Sources
- Federal Register, 9 November 2026: Extension of the Suspension of Expansion of End-User Controls for Affiliates of Certain Listed Entities
- Federal Register, 12 November 2025: One Year Suspension of Expansion of End-User Controls for Affiliates of Certain Listed Entities
- Skadden: BIS Extends Suspension of Affiliates Rule Through January 10, 2027
- Nixon Peabody: BIS formally suspends the Affiliates Rule until January 10, 2027
This article is general information about a regulatory development and is not legal advice.
